Newsbenzinga
Eli Lilly, Abbisko Expand Drug Hunt With $1.9 Billion Research Pact
· Published
Article summary
Abbisko Therapeutics signed a new Eli Lilly partnership worth up to $1.9 billion to develop novel medicines globally.
An excerpt from the original article.
Comments —
Loading comments…